Healthcare Triangle, Inc. Liquidation Value

Cash & Equivalents

$4.32M
As of 2026-03-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $4.32M
Total Obligations: -$23.48M
$-19.16M
Per share: $-10.38
Period: 2026-03-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $4.32M
AR: $8.37M
Total Obligations: -$23.48M
$-10.79M
Per share: $-5.85
Period: 2026-03-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $4.32M
AR: $8.37M
Inventory: N/A
Total Obligations: -$23.48M
$-10.79M
Per share: $-5.85
Period: 2026-03-31
incomplete 1 component missing — treated as $0 in formula. Why?
  • Inventory: not reported in this period (annual-only)

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-19.16M$-10.38
Liquid Liquidation Value$-10.79M$-5.85
Operating Liquidation Value$-10.79M$-5.85

Key Components (as of 2026-03-31)

Data as of 2026-03-31 from 10-Q filed 2026-05-14. View on SEC EDGAR →

Cash & Equivalents$4.32M
Accounts Receivable$8.37M
InventoryN/A
Current Liabilities$20.99M
Long-term Debt (?)$629,000
Op. Lease Liability (?)$700,000
Finance Lease (?)N/A
Shares Outstanding1.8M

Explore all 144 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2026-03-31$4.32M$8.37MN/A$3.29M$20.99M$629,000$700,000N/A
2025-12-31$7.62M$2.07M$3,000$744,000$12.79M$10.54MN/AN/A
2025-09-30$1.63M$2.44M$187,000$1.31M$3.91MN/AN/AN/A
2025-06-30$3.23M$1.86MN/A$2.07M$3.16MN/AN/AN/A
2025-03-31$6.83M$1.91MN/A$1.62M$3.21MN/AN/AN/A
2024-12-31$20,000$1.11M$2,000$2.54M$7.08MN/AN/AN/A
2024-10-09N/AN/AN/AN/AN/A$1.00BN/AN/A
2024-09-30$28,000$1.61MN/A$2.30M$6.08MN/AN/AN/A

Comments

SEC Filings

PeriodFormFiledLink
2026-03-31 10-Q 2026-05-14 View
2025-12-31 10-K 2026-04-15 View
2025-12-31 10-K/A 2026-04-16 View
2025-09-30 10-Q 2025-11-13 View
2025-06-30 10-Q 2025-08-14 View
2025-03-31 10-Q 2025-05-20 View
2024-12-31 10-K 2025-03-31 View
2024-09-30 10-Q 2024-11-14 View

AI Insights

AI Insight·Generated 2026-05-15

HCTI's liquidation posture as of March 31, 2026, is deeply negative. MFFAIS estimates cash liquidation value at -$15.7M, liquid liquidation value at -$13.6M, and operating liquidation value at -$13.6M. These figures reflect a balance sheet where haircut assets are insufficient to satisfy face-value liabilities by a substantial margin. The TAG_CONTEXT list provided is empty, meaning the filer emitted no XBRL-tagged balance sheet values that can be individually cited; all balance sheet analysis must be drawn from narrative disclosures. Key structural observations from MD&A and footnotes: (1) Current ratio deteriorated to 0.90 at March 31, 2026 from 1.33 at December 31, 2025, confirming the entity crossed into negative working capital territory during Q1 2026. (2) A business combination was completed during Q1 2026 (Customer Engagement Services segment acquired, contributing $6.87M of Q1 revenue), funded partly by $9.48M in Q1 financing inflows. Investing outflows of $6.02M versus nil in Q1 2025 reflect acquisition cash deployed. (3) Operating cash burn was $(6.86)M in Q1 2026, worsening from $(5.56)M in Q1 2025, driven by a net loss of $(6.20)M which included $2.44M of non-cash fair value charges on warrant/derivative instruments. (4) Cash on hand fell to $4.31M at March 31, 2026 from $7.62M implied at December 31, 2025 (net decrease of $3.31M). At current burn, this cash position represents roughly 1.9 quarters of operating outflows, with no disclosed committed credit facility at the parent level. (5) The $3.83M receivable from SecureKloud Technologies Limited (SKL), an unsecured, non-interest-bearing related-party advance — $3.20M for AI/software platform development and $0.63M for services — represents a significant recovery risk asset. Under liquidation, an unsecured advance to an affiliate for platform development work would face severe haircut or zero recovery. The filing does not separately XBRL-tag this receivable. (6) Intangible assets from the acquisition (technology platform, trademarks, IP) are tagged in the filing's XBRL structure but their values are not provided in the TAG_CONTEXT; under liquidation these would be zero-recovery. (7) The filing discloses ASC 842 operating lease obligations for building and vehicle leases in India; specific ROU asset and liability values are tagged but not in TAG_CONTEXT. These remain at face value in liquidation. (8) Debt stack includes convertible notes, Spanish-entity credit institution debt (multiple tranches across Caixabank, BBVA, Santander, Bankinter, Deutsche, Ibercaja, Unicaja, Abanca, Sabadell), an SBF recourse financing facility, and other borrowings; none are individually valued in TAG_CONTEXT. The current debt-equity ratio reported as 0.21 at March 31, 2026, down sharply from 1.08 at December 31, 2025, suggesting either significant equity issuance in Q1 or reclassification of debt. All debt settles at face value in liquidation. The structural conclusion is consistent with MFFAIS estimates: equity holders face negative recovery in a liquidation scenario, with the acquisition-driven asset base heavily weighted toward intangibles and related-party receivables that carry near-zero liquidation value.

Flags

Loading flags...

AI Insight Discussion

Loading...

Community Notes

Loading notes...

Questions

Loading questions...